Notice of Completion of Acquisition of Shares of Japan Hospice Holdings Inc.(Code Number:7061)
September 28, 2023 at 05:14 am EDT
Share
July 3, 2023
To Whom It May Concern:
Company name:
S U G I H o l d i n g s C o . , L t d .
Representative:
Katsunori Sugiura, Representative Director & President
(Code number: 7649, TSE Prime / NSE Premier)
Inquiries:
Makoto Kasai, General Manager, Business Planning Department
(T E L :
+ 8 1 - 5 6 2 - 4 5 - 2 7 4 4)
Notice of Completion of Acquisition of Shares of Japan Hospice Holdings Inc.
(Code Number: 7061)
SUGI Holdings Co., Ltd. (the "Company") has today completed the acquisition of the common shares of Japan Hospice Holdings Inc. (Code number: 7061, TSE Growth, Tadashi Takahashi, Representative Director
President; hereinafter "Japan Hospice"), which it announced in "Notice of a Capital and Business Partnership with Japan Hospice Holdings Inc." dated June 16, 2023, as follows:
1. Date of acquisition
July 3, 2023
2. Method of acquisition
The Company acquired 1,600,000 Japan Hospice shares today in a secondary
offering of shares conducted by Japan Hospice in accordance with "Notice of
Acquisition of Shares of Japan Hospice Holdings Inc. (Code Number: 7061)
That Falls under Acts Specified by Cabinet Order as Being Equivalent to a
Tender Offer" released on June 19, 2023.
For details of the secondary offering, please refer to the following press
releases by Japan Hospice: "Notice of Secondary Offering of Shares and
Changes to Major Shareholders and the Largest and Principal Shareholder"
dated June 16, 2023, "Notice of Agreement of Acquisition of Japan Hospice
Shares by the Acquirer Designated by Japan Hospice in the Secondary Offering
of Shares" dated June 19, 2023, and "Notice of Determination of Offering Price,
etc." dated June 26, 2023.
3. Number of shares acquired and acquisition price
(1)
Number of shares acquired
1,600,000 shares (19.91% of total number of issued shares)
(2)
Acquisition price
3,176 yen per share (total acquisition cost: 5,081,600,000 yen)
4. Future outlook
The impact of the capital and business partnership with Japan Hospice and the acquisition of the shares on the consolidated financial results of the Company for the fiscal year ending February 29, 2024 will be insignificant. However, we expect that they will contribute to the enhancement of the Company's financial results and corporate value over the medium to long term.
Sugi Holdings Co. Ltd. published this content on 27 September 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 September 2023 09:13:10 UTC.
SUGI HOLDINGS CO.,LTD. is a Japan-based holding company mainly engaged in management of the drug stores and dispensing business. Through its subsidiaries, the Company is engaged in the sale of medicines, health foods, cosmetics, daily necessities and prescription preparations, as well as the operation of local healthcare compliant drug store that tackles home healthcare in cooperation with regional medical personnel. The Company also operates visiting nursing stations that closely cooperate with regional medical institutions and social welfare operators, through the provision of visiting nursing services and in-home nursing care support services.